Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in New Onset Type 1 Diabetes
NCT00505375Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Feb 2008
- Primary completion
- May 2012
- Modality
- Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 2 trial of abatacept in type 1 diabetes mellitus (T1D), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Feb 2008; status: completed.
02
Drugs
abatacept
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00505375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00505375.